ArticleJournal of ovarian research2025
Integrated multi-omics analysis identifies TLR4-mediated mechanisms in ATBC-induced ovarian dysfunction and female infertility: A network toxicology, transcriptomic, and Mendelian randomization study.
Article in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advances in multi-omics and aging clock research for female reproductive health and aging.MedScience · 2026Review
- Druggable Targets for Pelvic Inflammatory Disease: Mendelian Randomization and Experimental Validation.Journal of inflammation research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundAcetyl tributyl citrate (ATBC), a widely used plasticizer, has raised concerns regarding its reproductive toxicity. However, its molecular mechanisms in female infertility and ovarian damage remain poorly characterized. This study employs an integrative computational framework to elucidate ATBC-associated targets and pathways, with validation through genetic epidemiology and molecular docking.
resultsWe identified 137 ovarian damage-related and 143 infertility-related ATBC targets, refined to 19 and 30 hub genes respectively. Pathway analysis revealed significant enrichment in apoptosis, oxidative stress response, and PI3 K-AKT signaling (p < 0.05). Transcriptomic validation showed differential expression of 7/10 infertility-related and 9/10 ovarian damage-related hub genes. Mendelian randomization implicated TLR4 as protective against infertility (OR = 0.76, 95% CI:0.62-0.99; P = 0.049). Molecular docking confirmed strong binding affinities between ATBC and key targets (TLR4: Vina score = -4.8 kcal/mol; ESR1: -7.5 kcal/mol).
conclusionsThis first multi-omics investigation of ATBC reproductive toxicity uncovers TLR4 as a critical mediator of ovarian dysfunction and infertility through inflammation-related pathways. Our findings provide novel mechanistic insights and suggest TLR4 modulation as a potential therapeutic strategy for chemical-induced reproductive disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.